TY - JOUR
T1 - Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance
AU - Cascio, Jason A.
AU - Haymaker, Cara L.
AU - Divekar, Rohit D.
AU - Zaghouani, Sarah
AU - Khairallah, Marie Therese
AU - Wan, Xiaoxiao
AU - Rowland, Linda M.
AU - Dhakal, Mermagya
AU - Chen, Weirong
AU - Zaghouani, Habib
PY - 2013/6/15
Y1 - 2013/6/15
N2 - Dendritic cells (DCs) have been shown to play a major role in oral tolerance, and this function has been associated with their ability to produce anti-inflammatory cytokines and to induce suppressive regulatory T cells. In this study, we demonstrate that upon oral administration of Ag, lamina propia (LP) DCs engage specific T cells and acquire a novel mechanism by which they transfer tolerance against diverse T cell specificities. Indeed, when Ig-myelin oligodendrocyte glycoprotein (MOG) carrying the MOG35-55 epitope was orally administered into either T cell-sufficient or -deficient mice, only the T cell-sufficient hosts yielded CD8α+ and CD8α- LP DCs that were able to transfer tolerance to a variety of MHC class II-restricted effector T cells. Surprisingly, these LP DCs upregulated programmed cell death ligand 1 during the initial interaction with MOG-specific T cells and used this inhibitory molecule to suppress activation of T cells regardless of Ag specificity. Furthermore, oral Ig-MOG was able to overcome experimental autoimmune encephalomyelitis induced with CNS homogenate, indicating that the DCs are able to modulate disease involving diverse T cell specificities. This previously unrecognized attribute potentiates DCs against autoimmunity.
AB - Dendritic cells (DCs) have been shown to play a major role in oral tolerance, and this function has been associated with their ability to produce anti-inflammatory cytokines and to induce suppressive regulatory T cells. In this study, we demonstrate that upon oral administration of Ag, lamina propia (LP) DCs engage specific T cells and acquire a novel mechanism by which they transfer tolerance against diverse T cell specificities. Indeed, when Ig-myelin oligodendrocyte glycoprotein (MOG) carrying the MOG35-55 epitope was orally administered into either T cell-sufficient or -deficient mice, only the T cell-sufficient hosts yielded CD8α+ and CD8α- LP DCs that were able to transfer tolerance to a variety of MHC class II-restricted effector T cells. Surprisingly, these LP DCs upregulated programmed cell death ligand 1 during the initial interaction with MOG-specific T cells and used this inhibitory molecule to suppress activation of T cells regardless of Ag specificity. Furthermore, oral Ig-MOG was able to overcome experimental autoimmune encephalomyelitis induced with CNS homogenate, indicating that the DCs are able to modulate disease involving diverse T cell specificities. This previously unrecognized attribute potentiates DCs against autoimmunity.
UR - http://www.scopus.com/inward/record.url?scp=84879093384&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1203552
DO - 10.4049/jimmunol.1203552
M3 - Article
C2 - 23686493
AN - SCOPUS:84879093384
SN - 0022-1767
VL - 190
SP - 6004
EP - 6014
JO - Journal of Immunology
JF - Journal of Immunology
IS - 12
ER -